z-logo
open-access-imgOpen Access
Proportional constrained longitudinal data analysis models for clinical trials in sporadic Alzheimer's disease
Author(s) -
Wang Guoqiao,
Liu Lei,
Li Yan,
Aschenbrenner Andrew J.,
Bateman Randall J.,
Delmar Paul,
Schneider Lon S.,
Kennedy Richard E.,
Cutter Gary R.,
Xiong Chengjie
Publication year - 2022
Publication title -
alzheimer's and dementia: translational research and clinical interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.49
H-Index - 30
ISSN - 2352-8737
DOI - 10.1002/trc2.12286
Subject(s) - disease , longitudinal data , clinical trial , alzheimer's disease , medicine , psychology , computer science , data mining
Clinical trials for sporadic Alzheimer's disease generally use mixed models for repeated measures (MMRM) or, to a lesser degree, constrained longitudinal data analysis models (cLDA) as the analysis model with time since baseline as a categorical variable. Inferences using MMRM/cLDA focus on the between‐group contrast at the pre‐determined, end‐of‐study assessments, thus are less efficient (eg, less power). Methods The proportional cLDA (PcLDA) and proportional MMRM (pMMRM) with time as a categorical variable are proposed to use all the post‐baseline data without the linearity assumption on disease progression. Results Compared with the traditional cLDA/MMRM models, PcLDA or pMMRM lead to greater gain in power (up to 20% to 30%) while maintaining type I error control. Discussion The PcLDA framework offers a variety of possibilities to model longitudinal data such as proportional MMRM (pMMRM) and two‐part pMMRM which can model heterogeneous cohorts more efficiently and model co‐primary endpoints simultaneously.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here